Free 2-Day Shipping On Orders $150+
Retatrutide

Vial products ship as dry lyophilized material unless the product format explicitly states otherwise.

10mL Vial99%+ PurityGLP-1 / Weight Management
10mL Vial

Retatrutide

Triple-agonist GLP-1/GIP/glucagon research peptide

$100.00
Research format / strength

Volume pricing

Per-unit price drops automatically as quantity increases.

Strength12+5+
10mg$100.00$95.00$90.00
20mg$170.00$161.50$153.00
40mg$300.00$285.00$270.00

Per-unit pricing at each quantity break, applied automatically at checkout.

Retatrutide is a next-generation triple-receptor agonist (GLP-1, GIP, and glucagon) under active research for its profound effects on metabolic regulation and body-composition models.

Research use only. Not for human consumption, veterinary use, or medical applications.

Format
10mL Vial
Use
For laboratory and research purposes only. Not for human consumption, veterinary use, or medical applications.
Lot documentation

Certificate of Analysis

Your lot number is stamped on the base of the vial or bottle. Match it to the list to open the certificate for the exact material you received.

Lots on file
13
Laboratory
AxisPharm, LLC
View lot certificates
Published research

What the literature reports

Retatrutide is an investigational triple agonist of GIP, GLP-1, and glucagon receptors that has been examined in phase 2 clinical trials for obesity, type 2 diabetes, and hepatic fat fraction.

  1. In a phase 2 trial in adults with obesity, investigators observed graded body-weight reductions across study arms at 48 weeks versus placebo.

  2. In a phase 2 trial in adults with type 2 diabetes, researchers reported greater HbA1c and body-weight reductions with retatrutide than with placebo or dulaglutide at higher study arms.

    phase 2 clinical trial Rosenstock et al., Lancet, 2023 ↗
  3. In a phase 2a substudy in participants with obesity and elevated liver fat, MRI-PDFF measurements showed large relative reductions in hepatic fat fraction versus placebo.

    phase 2a clinical substudy Sanyal et al., Nat Med, 2024 ↗

These summaries describe findings reported in published laboratory and clinical literature about this compound. They are provided for research context only. They are not claims about this product, and nothing here describes an intended use in humans or animals. This material is supplied strictly for laboratory research use.

Made in America. Documented lot by lot.

Most peptides sold in this category are imported in bulk, repackaged, and sold with no paperwork attached to the material in the bottle. Ours are synthesized in United States laboratories and every lot carries its own certificate.

Where is this material made?+
In United States laboratories. We buy from domestic synthesis rather than importing finished bulk from an overseas supplier and relabeling it. That is the reason we are able to name a specific laboratory, lot and test date for what you receive.
Why does a US laboratory matter?+
A domestic supply chain is shorter and documented end to end: identifiable facilities operating under US laboratory practice, and paperwork that follows one specific lot instead of a generic product description. It also means shorter transit and no repackaging between the laboratory and the customer.
What documentation comes with a lot?
A lot-specific Certificate of Analysis from an independent laboratory. The lot number is stamped on the base of the container — match it against the certificates listed on this page, or scan the QR code on the label, to open the report for the exact material shipped.
Where does my order ship from?+
Our United States facility, packed and dispatched domestically with tracking. Orders do not transit customs or get repackaged en route.